Genetic engineering of Streptomyces bingchenggensis to produce milbemycins A3/A4 as main components and eliminate the biosynthesis of nanchangmycin

Ji Zhang, Jing An, Ji Jia Wang, Yi Jun Yan, Hai Rong He, Xiang Jing Wang, Wen Sheng Xiang

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Milbemycins A3/A4 are important 16-membered macrolides which have been commercialized and widely used as pesticide and veterinary medicine. However, similar to other milbemycin producers, the production of milbemycins A3/A4 in Streptomyces bingchenggensis is usually accompanied with undesired by-products such as C5-O-methylmilbemycins B2/B3 (α-class) and β1/β2 (β-class) together with nanchangmycin. In order to obtain high yield milbemycins A3/A4-producing strains that produce milbemycins A3/A4 as main components, milD, a putative C5-O-methyltransferase gene of S. bingchenggensis, was biofunctionally investigated by heterologous expression in Escherichia coli. Enzymatic analysis indicated that MilD can catalyze both α-class (A3/A4) and β-class milbemycins (β11) into C5-O-methylmilbemycins B2/B3 and β1, respectively, suggesting little effect of furan ring formed between C6 and C8a on the C5-O-methylation catalyzed by MilD. Deletion of milD gene resulted in the elimination of C5-O-methylmilbemycins B2/B3 and β1/β2 together with an increased yield of milbemycins A3/A4 in disruption strain BCJ13. Further disruption of the gene nanLD encoding loading module of polyketide synthase responsible for the biosynthesis of nanchangmycin led to strain BCJ36 that abolished the production of nanchangmycin. Importantly, mutant strain BCJ36 (â̂†milDâ̂†nanLD) produced milbemycins A3/A4 as main secondary metabolites with a yield of 2312 ± 47 μg/ml, which was approximately 74 % higher than that of the initial strain S. bingchenggensis BC-109-6 (1326 ± 37 μg/ml).

Original languageEnglish (US)
Pages (from-to)10091-10101
Number of pages11
JournalApplied Microbiology and Biotechnology
Volume97
Issue number23
DOIs
StatePublished - Dec 1 2013
Externally publishedYes

Fingerprint

Genetic Engineering
Streptomyces
milbemycin
nanchangmycin
Polyketide Synthases
Veterinary Medicine
Macrolides
Gene Deletion
Methyltransferases
Pesticides
Methylation
Genes

Keywords

  • C5-O-methyltransferase
  • Gene disruption
  • Milbemycins
  • Nanchangmycin
  • Streptomyces bingchenggensis

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Genetic engineering of Streptomyces bingchenggensis to produce milbemycins A3/A4 as main components and eliminate the biosynthesis of nanchangmycin. / Zhang, Ji; An, Jing; Wang, Ji Jia; Yan, Yi Jun; He, Hai Rong; Wang, Xiang Jing; Xiang, Wen Sheng.

In: Applied Microbiology and Biotechnology, Vol. 97, No. 23, 01.12.2013, p. 10091-10101.

Research output: Contribution to journalArticle

Zhang, Ji ; An, Jing ; Wang, Ji Jia ; Yan, Yi Jun ; He, Hai Rong ; Wang, Xiang Jing ; Xiang, Wen Sheng. / Genetic engineering of Streptomyces bingchenggensis to produce milbemycins A3/A4 as main components and eliminate the biosynthesis of nanchangmycin. In: Applied Microbiology and Biotechnology. 2013 ; Vol. 97, No. 23. pp. 10091-10101.
@article{cfa66660aaf646078301dd9b8ac75fe2,
title = "Genetic engineering of Streptomyces bingchenggensis to produce milbemycins A3/A4 as main components and eliminate the biosynthesis of nanchangmycin",
abstract = "Milbemycins A3/A4 are important 16-membered macrolides which have been commercialized and widely used as pesticide and veterinary medicine. However, similar to other milbemycin producers, the production of milbemycins A3/A4 in Streptomyces bingchenggensis is usually accompanied with undesired by-products such as C5-O-methylmilbemycins B2/B3 (α-class) and β1/β2 (β-class) together with nanchangmycin. In order to obtain high yield milbemycins A3/A4-producing strains that produce milbemycins A3/A4 as main components, milD, a putative C5-O-methyltransferase gene of S. bingchenggensis, was biofunctionally investigated by heterologous expression in Escherichia coli. Enzymatic analysis indicated that MilD can catalyze both α-class (A3/A4) and β-class milbemycins (β11) into C5-O-methylmilbemycins B2/B3 and β1, respectively, suggesting little effect of furan ring formed between C6 and C8a on the C5-O-methylation catalyzed by MilD. Deletion of milD gene resulted in the elimination of C5-O-methylmilbemycins B2/B3 and β1/β2 together with an increased yield of milbemycins A3/A4 in disruption strain BCJ13. Further disruption of the gene nanLD encoding loading module of polyketide synthase responsible for the biosynthesis of nanchangmycin led to strain BCJ36 that abolished the production of nanchangmycin. Importantly, mutant strain BCJ36 ({\^a}̂†milD{\^a}̂†nanLD) produced milbemycins A3/A4 as main secondary metabolites with a yield of 2312 ± 47 μg/ml, which was approximately 74 {\%} higher than that of the initial strain S. bingchenggensis BC-109-6 (1326 ± 37 μg/ml).",
keywords = "C5-O-methyltransferase, Gene disruption, Milbemycins, Nanchangmycin, Streptomyces bingchenggensis",
author = "Ji Zhang and Jing An and Wang, {Ji Jia} and Yan, {Yi Jun} and He, {Hai Rong} and Wang, {Xiang Jing} and Xiang, {Wen Sheng}",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s00253-013-5255-5",
language = "English (US)",
volume = "97",
pages = "10091--10101",
journal = "Applied Microbiology and Biotechnology",
issn = "0175-7598",
publisher = "Springer Verlag",
number = "23",

}

TY - JOUR

T1 - Genetic engineering of Streptomyces bingchenggensis to produce milbemycins A3/A4 as main components and eliminate the biosynthesis of nanchangmycin

AU - Zhang, Ji

AU - An, Jing

AU - Wang, Ji Jia

AU - Yan, Yi Jun

AU - He, Hai Rong

AU - Wang, Xiang Jing

AU - Xiang, Wen Sheng

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Milbemycins A3/A4 are important 16-membered macrolides which have been commercialized and widely used as pesticide and veterinary medicine. However, similar to other milbemycin producers, the production of milbemycins A3/A4 in Streptomyces bingchenggensis is usually accompanied with undesired by-products such as C5-O-methylmilbemycins B2/B3 (α-class) and β1/β2 (β-class) together with nanchangmycin. In order to obtain high yield milbemycins A3/A4-producing strains that produce milbemycins A3/A4 as main components, milD, a putative C5-O-methyltransferase gene of S. bingchenggensis, was biofunctionally investigated by heterologous expression in Escherichia coli. Enzymatic analysis indicated that MilD can catalyze both α-class (A3/A4) and β-class milbemycins (β11) into C5-O-methylmilbemycins B2/B3 and β1, respectively, suggesting little effect of furan ring formed between C6 and C8a on the C5-O-methylation catalyzed by MilD. Deletion of milD gene resulted in the elimination of C5-O-methylmilbemycins B2/B3 and β1/β2 together with an increased yield of milbemycins A3/A4 in disruption strain BCJ13. Further disruption of the gene nanLD encoding loading module of polyketide synthase responsible for the biosynthesis of nanchangmycin led to strain BCJ36 that abolished the production of nanchangmycin. Importantly, mutant strain BCJ36 (â̂†milDâ̂†nanLD) produced milbemycins A3/A4 as main secondary metabolites with a yield of 2312 ± 47 μg/ml, which was approximately 74 % higher than that of the initial strain S. bingchenggensis BC-109-6 (1326 ± 37 μg/ml).

AB - Milbemycins A3/A4 are important 16-membered macrolides which have been commercialized and widely used as pesticide and veterinary medicine. However, similar to other milbemycin producers, the production of milbemycins A3/A4 in Streptomyces bingchenggensis is usually accompanied with undesired by-products such as C5-O-methylmilbemycins B2/B3 (α-class) and β1/β2 (β-class) together with nanchangmycin. In order to obtain high yield milbemycins A3/A4-producing strains that produce milbemycins A3/A4 as main components, milD, a putative C5-O-methyltransferase gene of S. bingchenggensis, was biofunctionally investigated by heterologous expression in Escherichia coli. Enzymatic analysis indicated that MilD can catalyze both α-class (A3/A4) and β-class milbemycins (β11) into C5-O-methylmilbemycins B2/B3 and β1, respectively, suggesting little effect of furan ring formed between C6 and C8a on the C5-O-methylation catalyzed by MilD. Deletion of milD gene resulted in the elimination of C5-O-methylmilbemycins B2/B3 and β1/β2 together with an increased yield of milbemycins A3/A4 in disruption strain BCJ13. Further disruption of the gene nanLD encoding loading module of polyketide synthase responsible for the biosynthesis of nanchangmycin led to strain BCJ36 that abolished the production of nanchangmycin. Importantly, mutant strain BCJ36 (â̂†milDâ̂†nanLD) produced milbemycins A3/A4 as main secondary metabolites with a yield of 2312 ± 47 μg/ml, which was approximately 74 % higher than that of the initial strain S. bingchenggensis BC-109-6 (1326 ± 37 μg/ml).

KW - C5-O-methyltransferase

KW - Gene disruption

KW - Milbemycins

KW - Nanchangmycin

KW - Streptomyces bingchenggensis

UR - http://www.scopus.com/inward/record.url?scp=84888194512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888194512&partnerID=8YFLogxK

U2 - 10.1007/s00253-013-5255-5

DO - 10.1007/s00253-013-5255-5

M3 - Article

C2 - 24077727

AN - SCOPUS:84888194512

VL - 97

SP - 10091

EP - 10101

JO - Applied Microbiology and Biotechnology

JF - Applied Microbiology and Biotechnology

SN - 0175-7598

IS - 23

ER -